News
LAB
2.350
+0.43%
0.010
Revenues Tell The Story For Standard BioTools Inc. (NASDAQ:LAB) As Its Stock Soars 42%
Simply Wall St · 15h ago
Weekly Report: what happened at LAB last week (0715-0719)?
Weekly Report · 4d ago
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024
Barchart · 07/17 07:01
Weekly Report: what happened at LAB last week (0708-0712)?
Weekly Report · 07/15 09:15
Weekly Report: what happened at LAB last week (0701-0705)?
Weekly Report · 07/08 09:16
Standard BioTools Shareholders Back Growth and Governance Plans
TipRanks · 07/01 20:32
Weekly Report: what happened at LAB last week (0624-0628)?
Weekly Report · 07/01 09:16
5 Medical Info Systems Stock to Buy for a Stable Portfolio
NASDAQ · 06/24 12:16
Weekly Report: what happened at LAB last week (0617-0621)?
Weekly Report · 06/24 09:16
Standard BioTools plans to sell 105.1M shares in secondary offering - filing
Standard BioTools plans to sell 105.1M shares in secondary offering. The company will not receive any proceeds from the sale of shares by the selling shareholders. Standard BioTools Inc. (NASDAQ:LAB) to sell up to 105.2M shares of common stock.
Seeking Alpha · 06/20 21:56
Analysts Offer Insights on Healthcare Companies: Standard BioTools (LAB), BioCryst (BCRX) and Alnylam Pharma (ALNY)
TipRanks · 06/20 11:30
Standard Biotools Filed For Offering Of Up To 105.1M Common Shares By The Selling Securityholders
Benzinga · 06/20 10:27
STANDARD BIOTOOLS INC FILES FOR OFFERING OF UP TO 105.1 MLN COMMON SHARES BY THE SELLING SECURITYHOLDERS - SEC FILING
Reuters · 06/20 10:01
Weekly Report: what happened at LAB last week (0610-0614)?
Weekly Report · 06/17 09:15
Weekly Report: what happened at LAB last week (0603-0607)?
Weekly Report · 06/10 09:16
Weekly Report: what happened at LAB last week (0527-0531)?
Weekly Report · 06/03 09:16
STANDARD BIOTOOLS PURCHASES THE CARTERRA® LSA-XT SYSTEM TO ACCELERATE DATA DELIVERY AND PROVIDE GREATER VALIDATION TO SOMASCAN CUSTOMERS
Reuters · 05/28 20:01
Weekly Report: what happened at LAB last week (0520-0524)?
Weekly Report · 05/27 09:17
Lab Instrument Industry Update - New Commercial Entrants
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry high risks. Cytek stands out as the best opportunity in the sector due to strong growth and manageable losses. The healthcare industry is facing immense headwinds.
Seeking Alpha · 05/23 13:17
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. The Dow Jones index closed lower by over 200 points on Wednesday. Recent notable insider transactions for penny stocks include Standard BioTools, Inc. And Barnwell Industries. Investors and traders interested in penny stocks can consider these transactions.
Benzinga · 05/23 12:47
More
Webull provides a variety of real-time LAB stock news. You can receive the latest news about STANDARD BIOTOOLS INC through multiple platforms. This information may help you make smarter investment decisions.
About LAB
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.